Gene Synthesis Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2033

 As per FMI, the Gene Synthesis Market is expected to reach US$ 779.4 million in 2023. Furthermore, the market is projected to record a CAGR of 19.2% during the forecast period, and by 2033, the valuation is expected to surge beyond US$ 4.5 billion.



The current biotechnology system relies heavily on the DNA synthesis technique, which is believed to be an important aspect of synthetic biology. This has helped healthcare professionals understand the structure of pathogens and other kinds of microorganisms. These factors are expected to surge the demand for gene synthesis during the forecast period.

For more information: https://www.futuremarketinsights.com/reports/gene-synthesis-market

A wide variety of methods are specifically employed for DNA complexity and length. These activities are specifically aimed at understanding the DNA/RNA structure. There are a lot of scientists who are working to understand their sequencing. Such methods would assist in developing medications that ensure physical wellness, which would brighten the prospects for gene synthesis.

Governments and private bodies worldwide are making massive investments in genome sequencing. In April 2021, the United States government announced an investment of US$ 1.7 billion in genome sequencing. Likewise, the United Kingdom government announced an investment of US$ 175 million in genomics research in December 2022.

The surging geriatric population across the globe has led to an increase in the adoption of gene synthesis. These help in the diagnosis and treatment of diseases. The synthesis of genes with cloning has led to reduced cost and reduction of time as well, which becomes crucial while treating elderly patients. Gene synthesis is also used for various applications, including gene therapy, molecular engineering, etc.

As per FMI market researchers, “Increased application of DNA synthesis technology, application of a wide variety of methods which help in understanding DNA complexity and length, colossal investments from government and private bodies, and various other factors are expected to surge the gene synthesis market share.”

Key Takeaways:

  • The market is expected to record a CAGR of 19.2% during the forecast period.
  • In 2023, the valuation is expected to be US$ 779.4 million.
  • By 2033, the estimation is anticipated to cross US$ 4.5 billion.
  • Based on the regional analysis, Asia Pacific is expected to be the leading market.
  • The United States market is expected to surge at 15.7%.
  • The United Kingdom market is projected to grow at 21.4% due to the increasing adoption of molecular engineering.
  • China market is anticipated to advance at 29.2% due to increasing development in Genomics.
  • Japan market is projected to register a CAGR of 24.1%.
  • South Korea's gene synthesis market is expected to record a growth rate of 21.6%.
  • Based on service type, the gene synthesis service segment is expected to hold the dominant market share and might surge to 16.5%.
  • Based on application, research and development is projected to be the leading segment and is expected to grow at 18.4%.

Competitive Landscape

The manufacturers operating in the DNA synthesis market are expected to make high investments in mergers and acquisitions. This is a key step towards expanding the market share. In addition, the key players are also forming strategic partnerships with players from other niches to access technologies that might benefit them. Furthermore, with concerns around carbon emissions, the manufacturers are also taking initiatives to cut carbon emissions.

Key developments in the market:

  • In September 2022, GenScript announced its collaboration with Gladstone-UCSF Institute of Genomic immunology for a Groundbreaking non-viral cell therapy study.
  • In January 2023, Twist Bioscience and CENTOGENE launched three panels to advance rare disease and hereditary cancer research and support diagnostics.

Gene Synthesis Market Segmentation

By Service:

  • Gene Synthesis Service (Standard Gene Service, Express Gene Service, Complex Gene Service, Custom Gene Synthesis Service)
  • Gene Fragments Service
  • GMP Gene Synthesis
  • Others

By Application:

  • Diagnostics
  • Therapeutics
  • Research and Development Activities
  • Others

By End User:

  • Academic and Research Institutes
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organization

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more